Abstract
Prostate cancer is a leading cause of cancer death in men in Western countries. Although progress has been made in therapies for cases where there is early diagnosis and disease is localized, current therapies for advanced prostate cancer still remain inadequate and do not provide a cure. Due to the particularly long latency and unpredictable, slow progression of prostate cancer, herbal medicine may be a suitable alternative for protection against the disease with potential for development for long-term use without significant side-effects. Research on potential drug molecules from herbal medicines is slowly emerging for prostate cancer treatment; however, investigations are still hampered by various technical concerns such as a lack of validated drug targets, lack of animal models relevant to the human disease, as well as a lack of strategies and methodologies to effectively analyze the active ingredients contained in herbal medicines, their pharmacokinetics, pharmacodynamics and so on. Here, we summarize recent advances in anticancer herbal medicine research for in vivo prostate cancer treatment. The most promising candidates are currently at the preclinical study stage and include the ethanol extracts of ka-mi-kae-kyuk-tang, a cocktail of ten Chinese and Korean herbs; honokiol, a biphenolic compound isolated from Magnolia officinalis (Hòupò in Chinese); and Wedelia chinensis. Potential toxicities or severe side effects as a result of long-term use, which are the main concerns that still need to be investigated prior to the commencement of clinical studies of these herbs and herbal formulas are discussed in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alam MI, Gomes A (2003) Snake venom neutralization by Indian medicinal plants (Vitex negundo and Emblica officinalis) root extracts. J Ethnopharmacol 86:75–80
Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M (2010) B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464:302–305
Attard G, Cooper CS, de Bono JS (2009) Steroid hormone receptors in prostate cancer: a hard habit to break? Cancer Cell 16:458–462
Beljanski M, Beljanski MS (1986) Three alkaloids as selective destroyers of cancer cells in mice. Synergy with classic anticancer drugs. Oncology 43:198–203
Bemis DL, Capodice JL, Gorroochurn P, Katz AE, Buttyan R (2006) Anti-prostate cancer activity of a beta-carboline alkaloid enriched extract from Rauwolfia vomitoria. Int J Oncol 29:1065–1073
Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66:1234–1240
Chan JY, Tang PM, Hon PM, Au SW, Tsui SK, Waye MM et al (2006) Pheophorbide a, a major antitumor component purified from Scutellaria barbata, induces apoptosis in human hepatocellular carcinoma cells. Planta Med 72:28–33
Chao JC, Chiang SW, Wang CC, Tsai YH, Wu MS (2006) Hot water-extracted Lycium barbarum and Rehmannia glutinosa inhibit proliferation and induce apoptosis of hepatocellular carcinoma cells. World J Gastroenterol 12:4478–4484
Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S et al (2004) Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol 10:3459–3463
Chen S, Gao J, Halicka HD, Traganos F, Darzynkiewicz Z (2008) Down-regulation of androgen-receptor and PSA by phytochemicals. Int J Oncol 32:405–411
Chen Z, Soo MY, Srinivasan N, Tan BK, Chan SH (2009) Activation of macrophages by polysaccharide-protein complex from Lycium barbarum L. Phytother Res 23:1116–1122
Collins L, Zhu T, Guo J, Xiao ZJ, Chen CY (2006) Phellinus linteus sensitises apoptosis induced by doxorubicin in prostate cancer. Br J Cancer 95:282–288
Cuellar MJ, Giner RM, Recio MC, Manez S, Rios JL (2001) Topical anti-inflammatory activity of some Asian medicinal plants used in dermatological disorders. Fitoterapia 72:221–229
Cunha GR (2008) Mesenchymal-epithelial interactions: past, present, and future. Differentiation 76:578–586
Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ et al (1987) The endocrinology and developmental biology of the prostate. Endocr Rev 8:338–362
de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L et al (2011) Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 364:1995–2005
De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG et al (2007) Inflammation in prostate carcinogenesis. Nat Rev Cancer 7:256–269
Dharmasiri MG, Jayakody JR, Galhena G, Liyanage SS, Ratnasooriya WD (2003) Anti-inflammatory and analgesic activities of mature fresh leaves of Vitex negundo. J Ethnopharmacol 87:199–206
Ellem SJ, Risbridger GP (2010) Aromatase and regulating the estrogen:androgen ratio in the prostate gland. J Steroid Biochem Mol Biol 118:246–251
Ellem SJ, Wang H, Poutanen M, Risbridger GP (2009) Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy. Am J Pathol 175:1187–1199
Gan L, Zhang SH, Liu Q, Xu HB (2003) A polysaccharide-protein complex from Lycium barbarum upregulates cytokine expression in human peripheral blood mononuclear cells. Eur J Pharmacol 471:217–222
Gan L, Hua ZS, Liang YX, BI XH (2004) Immunomodulation and antitumor activity by a polysaccharide-protein complex from Lycium barbarum. Int Immunopharmacol 4:563–569
Gao D, Gao Y, Bai P (2003) Influence of Scutellaria barbata on calcium beaconage of cervix cancer cells. Zhong Yao Cai 26:730–733
Garcia GE, Nicole A, Bhaskaran S, Gupta A, Kyprianou N, Kumar AP (2006) Akt-and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine, a Phellodendron amurense extract. Neoplasia 8:523–533
Goh D, Lee YH, Ong ES (2005) Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. J Agric Food Chem 53:8197–8204
Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO et al (1995) Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92:3439–3443
Guo J, Zhu T, Collins L, Xiao ZX, Kim SH, Chen CY (2007a) Modulation of lung cancer growth arrest and apoptosis by Phellinus Linteus. Mol Carcinog 46:144–154
Guo J, Jiang C, Wang Z, Lee HJ, Hu H, Malewicz B et al (2007b) A novel class of pyranocoumarin anti-androgen receptor signaling compounds. Mol Cancer Ther 6:907–917
Hahm ER, Singh SV (2007) Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Mol Cancer Ther 6:2686–2695
He RR, Xie G, Yao XS, Kurihara H (2009) Effect of cocoa tea (Camellia ptilophylla) co-administrated with green tea on ambulatory behaviors. Biosci Biotechnol Biochem 73:957–960
He YL, Ying Y, Xu YL, Su JF, Luo H, Wang HF (2005) Effects of Lycium barbarum polysaccharide on tumor microenvironment T-lymphocyte subsets and dendritic cells in H22-bearing mice. Zhong Xi Yi Jie He Xue Bao 3:374–377
Hibasami H, Achiwa Y, Katsuzaki H, Imai K, Yoshioka K, Nakanishi K et al (1998) Honokiol induces apoptosis in human lymphoid leukemia Molt 4B cells. Int J Mol Med 2:671–673
Ishani A, MacDonald R, Nelson D, Rutks I, Wilt TJ (2000) Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. Am J Med 109:654–664
Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P et al (2003) A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 97:1442–1446
Jatoi A, Burch P, Hillman D, Vanyo JM, Dakhil S, Nikcevich D et al (2007) A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Urology 69:289–294
Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300
Jia JM, Wu CF, Liu W, Yu H, Hao Y, Zheng JH et al (2005) Antiinflammatory and analgesic activities of the tissue culture of Saussurea involucrata. Biol Pharm Bull 28:1612–1614
Jiang C, Lee HJ, Li GX, Guo J, Malewicz B, Zhao Y et al (2006) Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer. Cancer Res 66:453–463
Kim EK, Kwon KB, Han MJ, Song MY, Lee JH, Ko YS et al (2007) Induction of G1 arrest and apoptosis by Scutellaria barbata in the human promyelocytic leukemia HL-60 cell line. Int J Mol Med 20:123–128
Kumar AP, Bhaskaran S, Ganapathy M, Crosby K, Davis MD, Kochunov P et al (2007) Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract. Clin Cancer Res 13:2784–2794
Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S (2008) Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol 167:71–77
Kurihara H, Shibata H, Fukui Y, Kiso Y, Xu JK, Yao XS et al (2006) Evaluation of the hypolipemic property of Camellia sinensisVar. ptilophylla on postprandial hypertriglyceridemia. J Agric Food Chem 54:4977–4981
Kwan W, Duncan G, Van Patten C, Liu M, Lim J (2010) A Phase II trial of a soy beverage for subjects without clinical disease with rising prostate-specific antigen after radical radiation for prostate cancer. Nutr Cancer 62:198–207
Lee HJ, Lee EO, Rhee YH, Ahn KS, Li GX, Jiang C et al (2006) An Oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis. Carcinogenesis 27:2455–2463
Lee HJ, Lee EO, Lee JH, Lee KS, Kim KH, Kim SH et al (2009) In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin. Am J Chin Med 37:127–142
Leu CH, Li CY, Yao X, Wu TS (2006) Constituents from the leaves of Phellodendron amurense and their antioxidant activity. Chem Pharm Bull (Tokyo) 54:1308–1311
Levin RM, Das AK (2000) A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens. Urol Res 28:201–209
Li TSC (2009) Chinese and related North American herbs: phytopharmacology and therapeutic values. CRC Press, Boca Raton
Lin FM, Chen LR, Lin EH, Ke FC, Chen HY, Tsai MJ et al (2007) Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells. Carcinogenesis 28:2521–2529
Lin JM, Liu Y, Luo RC (2006) Effect of Scutellaria barbata extract against human hepatocellular Hep-G2 cell proliferation and its mechanism. Nan Fang Yi Ke Da Xue Xue Bao 26:975–977
Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL et al (2007) Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446:690–694
Luo Q, Li Z, Yan J, Zhu F, Xu RJ, Cai YZ (2009) Lycium barbarum polysaccharides induce apoptosis in human prostate cancer cells and inhibits prostate cancer growth in a xenograft mouse model of human prostate cancer. J Med Food 12:695–703
McCarty MF (2004) Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy. Integr Cancer Ther 3:349–380
McNeal JE (1969) Origin and development of carcinoma in the prostate. Cancer 23:24–34
McNeal JE (1981) The zonal anatomy of the prostate. Prostate 2:35–49
McNeal JE (1988) Normal histology of the prostate. Am J Surg Pathol 12:619–633
Mori H, Fuchigami M, Inoue N, Nagai H, Koda A, Nishioka I (1994) Principle of the bark of Phellodendron amurense to suppress the cellular immune response. Planta Med 60:445–449
Mori H, Fuchigami M, Inoue N, Nagai H, Koda A, Nishioka I et al (1995) Principle of the bark of Phellodendron amurense to suppress the cellular immune response: effect of phellodendrine on cellular and humoral immune responses. Planta Med 61:45–49
Nelson PS, Montgomery B (2003) Unconventional therapy for prostate cancer: good, bad or questionable? Nat Rev Cancer 3:845–858
Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM et al (2008) Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci USA 105:12182–12187
Oh WK, Kantoff PW, Weinberg V, Jones G, Rini BI, Derynck MK et al (2004) Prospective, multicenter, randomized Phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. J Clin Oncol 22:3705–3712
Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ et al (2006) Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 12:4018–4026
Park EJ, Zhao YZ, Kim YH, Lee BH, Sohn DH (2005) Honokiol induces apoptosis via cytochrome c release and caspase activation in activated rat hepatic stellate cells in vitro. Planta Med 71:82–84
Park EK, Rhee HI, Jung HS, Ju SM, Lee YA, Lee SH et al (2007) Antiinflammatory effects of a combined herbal preparation (RAH13) of Phellodendron amurense and Coptis chinensis in animal models of inflammation. Phytother Res 21:746–750
Peng L, Khan N, Afaq F, Ye C, Mukhtar H (2010) In vitro and in vivo effects of water extract of white cocoa tea (Camellia ptilophylla) against human prostate cancer. Pharm Res 27:1128–1137
Pienta KJ, Bradley D (2006) Mechanisms underlying the development of androgen-independent prostate cancer. Clin Cancer Res 12:1665–1671
Qiu J, Xue X, Chen F, Li C, Bolat N, Wang X et al (2010) Quality evaluation of snow lotus (Saussurea): quantitative chemical analysis and antioxidant activity assessment. Plant Cell Rep 29:1325–1337
Ricke WA, Ishii K, Ricke EA, Simko J, Wang Y, Hayward SW et al (2006) Steroid hormones stimulate human prostate cancer progression and metastasis. Int J Cancer 118:2123–2131
Ricke WA, Wang Y, Cunha GR (2007) Steroid hormones and carcinogenesis of the prostate: the role of estrogens. Differentiation 75:871–882
Sakr WA, Grignon DJ, Crissman JD, Heilbrun LK, Cassin BJ, Pontes JJ et al (1994) High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases. In Vivo 8:439–443
Scher HI, Sawyers CL (2005) Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol 23:8253–8261
Seeram NP (2008) Berry fruits: compositional elements, biochemical activities, and the impact of their intake on human health, performance, and disease. J Agric Food Chem 56:627–629
Shabbir M, Love J, Montgomery B (2008) Phase I trial of PC-Spes2 in advanced hormone refractory prostate cancer. Oncol Rep 19:831–835
Shen MM, Abate-Shen C (2010) Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 24:1967–2000
Shenouda NS, Sakla MS, Newton LG, Besch-Williford C, Greenberg NM, MacDonald RS et al (2007) Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo. Endocrine 31:72–81
Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M et al (2007) Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 109:1279–1289
Small EJ, Frohlich MW, Bok R, Shinohara K, Grossfeld G, Rozenblat Z et al (2000) Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol 18:3595–3603
Strong KM (2004) African plum and benign prostatic hypertrophy. J Herb Pharmacother 4:41–46
Takimoto CH, Glover K, Huang X, Hayes SA, Gallot L, Quinn M et al (2003) Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer. Cancer Epidemiol Biomarkers Prev 12:1213–1221
Tandon VR, Gupta RK (2006) Vitex negundo Linn (VN) leaf extract as an adjuvant therapy to standard anti-inflammatory drugs. Indian J Med Res 124:447–450
Timms BG (2008) Prostate development: a historical perspective. Differentiation 76:565–577
Tsai CH, Lin FM, Yang YC, Lee MT, Cha TL, Wu GJ et al (2009) Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice. Clin Cancer Res 15:5435–5444
Tsuji T, Du W, Nishioka T, Chen L, Yamamoto D, Chen CY (2010) Phellinus linteus extract sensitizes advanced prostate cancer cells to apoptosis in athymic nude mice. PLoS One 5:e9885
Voskoglou-Nomikos T, Pater JL, Seymour L (2003) Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res 9:4227–4239
Walsh PC (2005) Prospective, multicenter, randomized Phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. J Urol 173:1966–1967
Wang T, Chen F, Chen Z, Wu YF, Xu XL, Zheng S et al (2004a) Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol 10:2205–2208
Wang WS, Zhou YW, Ye YH, Du N (2004b) Studies on the flavonoids in herb from Scutellaria barbata. Zhongguo Zhong Yao Za Zhi 29:957–959
Wasser SP (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60:258–274
Way TD, Lee JC, Kuo DH, Fan LL, Huang CH, Lin HY et al (2010) Inhibition of epidermal growth factor receptor signaling by Saussurea involucrata, a rare traditional Chinese medicinal herb, in human hormone-resistant prostate cancer PC-3 cells. J Agric Food Chem 58:3356–3365
White J (2002) PC-SPES – a lesson for future dietary supplement research. J Natl Cancer Inst 94:1261–1263
Wong BY, Nguyen DL, Lin T, Wong HH, Cavalcante A, Greenberg NM et al (2009) Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice. Eur J Cancer Prev 18:331–341
Wu CT, Altuwaijri S, Ricke WA, Huang SP, Yeh S, Zhang C et al (2007) Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc Natl Acad Sci USA 104:12679–12684
Yancik R (2005) Population aging and cancer: a cross-national concern. Cancer J 11:437–441
Yang CS, Wang X, Lu G, Picinich SC (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429–439
Yang SE, Hsieh MT, Tsai TH, Hsu SL (2002) Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochem Pharmacol 63:1641–1651
Ye F, Jiang S, Volshonok H, Wu J, Zhang DY (2007) Molecular mechanism of anti-prostate cancer activity of Scutellaria baicalensis extract. Nutr Cancer 57:100–110
Yin X, Zhou J, Jie C, Xing D, Zhang Y (2004) Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci 75:2233–2244
Zhang L, Lee KC, Bhojani MS, Khan AP, Shilman A, Holland EC et al (2007) Molecular imaging of Akt kinase activity. Nat Med 13:1114–1119
Zhang M, Chen H, Huang J, Li Z, Zhu C, Zhang S (2005) Effect of lycium barbarum polysaccharide on human hepatoma QGY7703 cells: inhibition of proliferation and induction of apoptosis. Life Sci 76:2115–2124
Zhou Y, Liu YE, Cao J, Zeng G, Shen C, Li Y et al (2009) Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth. Clin Cancer Res 15:5161–5169
Zhu P, Baek SH, Bourk EM, Ohgi KA, Garcia-Bassets I, Sanjo H et al (2006) Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 124:615–629
Zhu T, Guo J, Collins L, Kelly J, Xiao ZJ, Kim SH et al (2007) Phellinus linteus activates different pathways to induce apoptosis in prostate cancer cells. Br J Cancer 96:583–590
Zhu T, Kim SH, Chen CY (2008) A medicinal mushroom: Phellinus linteus. Curr Med Chem 15:1330–1335
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Chen, YR., Hsiao, PW., Lin, FM., Wu, GJ., Tsai, CH. (2012). Evidence-based Anticancer Materia Medica for Prostate Cancer. In: Cho, W. (eds) Materia Medica for Various Cancers. Evidence-based Anticancer Complementary and Alternative Medicine, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1983-5_6
Download citation
DOI: https://doi.org/10.1007/978-94-007-1983-5_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-1982-8
Online ISBN: 978-94-007-1983-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)